摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-(4-(3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-ylamino)phenyl)acetamide | 1228445-91-7

中文名称
——
中文别名
——
英文名称
N-(3-(4-(3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-ylamino)phenyl)acetamide
英文别名
N-[3-[[4-(3,4-dihydro-1H-isoquinolin-2-yl)pyrimidin-2-yl]amino]phenyl]acetamide
N-(3-(4-(3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-ylamino)phenyl)acetamide化学式
CAS
1228445-91-7
化学式
C21H21N5O
mdl
——
分子量
359.431
InChiKey
CHBCVOUDKVRLEZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    70.2
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Identification of a Potent, State-Dependent Inhibitor of Nav1.7 with Oral Efficacy in the Formalin Model of Persistent Pain
    摘要:
    Clinical human genetic studies have recently identified the tetrodotoxin (TTX) sensitive neuronal voltage gated sodium channel Nav1.7 (SCN9A) as a critical mediator of pain sensitization. Herein, we report structure-activity relationships for a novel series of 2,4-diaminotriazines that inhibit hNav1.7. Optimization efforts culminated in compound 52, which demonstrated pharmacokinetic properties appropriate for in vivo testing in rats. The binding site, of compound 52 on Nav1.7 was determined to be distinct from that of local anesthetics. Compound 52 inhibited tetrodotoxin-sensitive sodium channels recorded from rat sensory neurons and exhibited modest selectivity against the hERG potassium channel and against cloned and native tetrodotoxin-resistant sodium channels. Upon oral administration to rats, compound 52 produced dose- and exposure-dependent efficacy in the formalin model of pain.
    DOI:
    10.1021/jm200018k
点击查看最新优质反应信息

文献信息

  • [EN] STEM CELL CULTURES<br/>[FR] CULTURES DE CELLULES SOUCHES
    申请人:SCRIPPS RESEARCH INST
    公开号:WO2010065721A1
    公开(公告)日:2010-06-10
    The present invention relates compounds for stabilizing cells and methods of their use.
    本发明涉及用于稳定细胞的化合物及其使用方法。
  • STEM CELL CULTURES
    申请人:Xu Yue
    公开号:US20110294761A1
    公开(公告)日:2011-12-01
    The present invention relates compounds for stabilizing cells and methods of their use.
    本发明涉及用于细胞稳定化的化合物及其使用方法。
  • Stem cell cultures
    申请人:THE SCRIPPS RESEARCH INSTITUTE
    公开号:EP2789618A1
    公开(公告)日:2014-10-15
    The present invention relates to compounds for stabilising cells and methods of their use.
    本发明涉及用于稳定细胞的化合物及其使用方法。
  • A COMPOSITION COMPRISING STEM CELL CULTURES
    申请人:The Scripps Research Institute
    公开号:EP3936508A1
    公开(公告)日:2022-01-12
    The present invention relates to compounds for stabilising cells and methods of their use.
    本发明涉及用于稳定细胞的化合物及其使用方法。
  • Methods of enhancing cell survival of stem cells
    申请人:The Scripps Research Institute
    公开号:US10351822B2
    公开(公告)日:2019-07-16
    The present invention relates compounds for stabilizing cells and methods of their use.
    本发明涉及用于稳定细胞的化合物及其使用方法。
查看更多